UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 524

Sortiert nach

COVID-19 and African Americans

JAMA : the journal of the American Medical Association, 2020-05, Vol.323 (19), p.1891

Yancy, Clyde W

2020

Volltextzugriff (PDF)

Academic Medicine and Black Lives Matter: Time for Deep Listening

JAMA : the journal of the American Medical Association, 2020-08, Vol.324 (5), p.435

Yancy, Clyde W

2020

Volltextzugriff (PDF)

Heart Failure with Preserved Ejection Fraction in Women

Heart failure clinics, 2019-01, Vol.15 (1), p.9-18

2019

Volltextzugriff (PDF)

Rhythm Control Versus Rate Control in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction: Insights From Get With The Guidelines-Heart Failure

Journal of the American Heart Association, 2019-12, Vol.8 (24), p.e011560-e011560

2019

Volltextzugriff (PDF)

Initiation, Continuation, or Withdrawal of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction

Journal of the American Heart Association, 2017-02, Vol.6 (2), p.n/a

2017

Volltextzugriff (PDF)

Regional Variations in Heart Failure Quality and Outcomes: Get With The Guidelines-Heart Failure Registry

Journal of the American Heart Association, 2021-04, Vol.10 (7), p.e018696-e018696

2021

Volltextzugriff (PDF)

Diversity in Medical Schools-Need for a New Bold Approach

JAMA : the journal of the American Medical Association, 2021-01, Vol.325 (1), p.31

2021

Volltextzugriff (PDF)

Impaired Cardiac Function and Cognitive Brain Aging

Canadian journal of cardiology, 2017-12, Vol.33 (12), p.1587-1596

2017

Volltextzugriff (PDF)

Use of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Comorbid Diabetes Mellitus or Chronic Kidney Disease

Journal of the American Heart Association, 2017-12, Vol.6 (12), p.n/a

2017

Volltextzugriff (PDF)

Home Health Care Use and Post-Discharge Outcomes After Heart Failure Hospitalizations

JACC. Heart failure, 2020-12, Vol.8 (12), p.1038-1049

2020

Volltextzugriff (PDF)

Implementation of a culturally competent APOL1 genetic testing programme into living donor evaluation: A two-site, non-randomised, pre–post trial design

BMJ open, 2023-05, Vol.13 (5), p.e067657-e067657

2023

Volltextzugriff (PDF)

Change the Name of the Blalock-Taussig Shunt to Blalock-Thomas-Taussig Shunt

JAMA surgery, 2022-04, Vol.157 (4), p.287

2022

Volltextzugriff (PDF)

Clinical Profile, Health Care Costs, and Outcomes of Patients Hospitalized for Heart Failure With Severely Reduced Ejection Fraction

Journal of the American Heart Association, 2023-05, Vol.12 (10), p.e028820-e028820

2023

Volltextzugriff (PDF)

Association of 30-Day Readmission Metric for Heart Failure Under the Hospital Readmissions Reduction Program With Quality of Care and Outcomes

JACC. Heart failure, 2016-12, Vol.4 (12), p.935-946

2016

Volltextzugriff (PDF)

Health equity in heart failure

Progress in cardiovascular diseases, 2024-01, Vol.82, p.55-60

2024

Volltextzugriff (PDF)

Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes

Journal of the American College of Cardiology, 2017-11, Vol.70 (20), p.2476-2486

2017

Volltextzugriff (PDF)

ACC/AHA 2008 guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons

Circulation (New York, N.Y.), 2008-08, Vol.118 (8), p.887-896

2008

Volltextzugriff (PDF)

Clinical Effectiveness of Sacubitril/Valsartan Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction

Journal of the American Heart Association, 2021-08, Vol.10 (16), p.e021459-e021459

2021

Volltextzugriff (PDF)

2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee

Journal of the American College of Cardiology, 2021-02, Vol.77 (6), p.772-810

2021

Volltextzugriff (PDF)

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

Journal of the American College of Cardiology, 2019-07, Vol.74 (1), p.104-132

2019

Volltextzugriff (PDF)

Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality

JAMA cardiology, 2020-07, Vol.5 (7), p.751

2020

Volltextzugriff (PDF)

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Journal of the American College of Cardiology, 2022-05, Vol.79 (17), p.e263-e421

2022

Volltextzugriff (PDF)

Short‐ and Long‐term Rehospitalization and Mortality for Heart Failure in 4 Racial/Ethnic Populations

Journal of the American Heart Association, 2014-10, Vol.3 (5), p.e001134-n/a

2014

Volltextzugriff (PDF)

The Hospital Readmission Reduction Program Is Associated With Fewer Readmissions, More Deaths: Time to Reconsider

Journal of the American College of Cardiology, 2017-10, Vol.70 (15), p.1931-1934

2017

Volltextzugriff (PDF)

New Biomarkers in Heart Failure: The Bar is High

Journal of cardiac failure, 2023-02, Vol.29 (2), p.168-170

2023

Volltextzugriff (PDF)

1 – 25 von 524

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(489)
Mit Volltextzugriff
(433)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(254)
Science & Technology
(247)
Life Sciences & Biomedicine
(246)
Cardiovascular System & Cardiology
(193)
Cardiac & Cardiovascular Systems
(190)
Heart Failure
(139)
Female
(63)
United States
(62)
Heart Failure - Therapy
(61)
Cardiology
(59)
Male
(58)
Heart Failure - Drug Therapy
(54)
Hospitalization
(47)
Aged
(43)
Heart
(40)
United States - Epidemiology
(40)
American Heart Association
(38)
Biological And Medical Sciences
(38)
Risk Factors
(38)
Medical Sciences
(37)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

COVID-19 and African Americans

Academic Medicine and Black Lives Matter: Time for Deep Listening

Heart Failure with Preserved Ejection Fraction in Women

Rhythm Control Versus Rate Control in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction: Insights From Get With The Guidelines-Heart Failure

Initiation, Continuation, or Withdrawal of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction

Regional Variations in Heart Failure Quality and Outcomes: Get With The Guidelines-Heart Failure Registry

Diversity in Medical Schools-Need for a New Bold Approach

Impaired Cardiac Function and Cognitive Brain Aging

Use of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Comorbid Diabetes Mellitus or Chronic Kidney Disease

Home Health Care Use and Post-Discharge Outcomes After Heart Failure Hospitalizations

Implementation of a culturally competent APOL1 genetic testing programme into living donor evaluation: A two-site, non-randomised, pre–post trial design

Change the Name of the Blalock-Taussig Shunt to Blalock-Thomas-Taussig Shunt

Clinical Profile, Health Care Costs, and Outcomes of Patients Hospitalized for Heart Failure With Severely Reduced Ejection Fraction

Association of 30-Day Readmission Metric for Heart Failure Under the Hospital Readmissions Reduction Program With Quality of Care and Outcomes

Health equity in heart failure

Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes

Clinical Effectiveness of Sacubitril/Valsartan Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction

2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Short‐ and Long‐term Rehospitalization and Mortality for Heart Failure in 4 Racial/Ethnic Populations

The Hospital Readmission Reduction Program Is Associated With Fewer Readmissions, More Deaths: Time to Reconsider

New Biomarkers in Heart Failure: The Bar is High

Aktive Filter

Suchergebnisse filtern